Lb Pharmaceuticals (LBRX) Retained Earnings (2024 - 2026)

Lb Pharmaceuticals' Retained Earnings history runs 3 years deep, the most recent figure standing at $208000.0 for Q1 2026.

• In Q1 2026, Retained Earnings changed N/A year-over-year to $208000.0; the TTM figure through Mar 2026 stood at $208000.0 (changed N/A YoY), while the FY2025 annual figure was -$129.5 million, down 24.16% from the prior year.
• Retained Earnings was $208000.0 for Q1 2026 at Lb Pharmaceuticals, up from -$129.5 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $208000.0 in Q1 2026 to a low of -$129.5 million in Q4 2025.
• Historically, Retained Earnings has averaged -$58.4 million across 3 years, with a median of -$52.2 million in 2024.
• Biggest YoY gain for Retained Earnings was 24.16% in 2025; the steepest drop was 24.16% in 2025.
• A 3-year view of Retained Earnings shows it stood at -$104.3 million in 2024, then decreased by 24.16% to -$129.5 million in 2025, then surged by 100.16% to $208000.0 in 2026.
• The last three Retained Earnings figures came in at $208000.0 (Q1 2026), -$129.5 million (Q4 2025), and -$53000.0 (Q3 2025), per Business Quant data.